Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Batch-to-batch consistency and safety trial of Group A and Group C Meningococcal Conjugate Vaccine in healthy infants aged 6-11 months
CTR20234201Phase 4Completed
- Sponsor
- Olin Biological
- Start
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal group A and C conjugate vaccine in meningococcal meningitis, sponsored by Olin Biological. Started Dec 2023; status: completed.
02
Drugs
meningococcal group A and C conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20234201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234201.